TB Diagnostics Pipeline: Testing Access & Opportunities 2024

Treatment Action Group presentation on tuberculosis diagnostic gaps and the critical need to improve TB testing access globally. Highlights that 30% of TB cases remain undiagnosed and only 47% receive WHO-recommended rapid molecular testing, emphasizing urgent investment in diagnostic tools and screening approaches.